scPhar­ma­cu­ti­cals rais­es $45M B round; Strug­gling Ni­valis and Acu­ra take stock of “strate­gic al­ter­na­tives”

• Lex­ing­ton, MA-based scPhar­ma­ceu­ti­cals, which is tak­ing gener­ic drugs and re­for­mu­lat­ing them for sub­cu­ta­neous in­jec­tion, has raised $45.6 mil­lion in its Se­ries B round …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER